FDA Drug Application (087655) for SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE by VANGARD

Back to FDA Applications sponsored by VANGARD

Application Number087655
Product Number001
FormTABLET;ORAL
Dosage25MG;25MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; SPIRONOLACTONE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient SPIRONOLACTONE5


Back to FDA Applications sponsored by VANGARD